DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Lebrun C, Bourg V, Bresch S. et al.
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis.
J Neuroimmunol 2016;
298: 79-81
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.